Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:PRTK

Paratek Pharmaceuticals (PRTK) Stock Price, News & Analysis

Paratek Pharmaceuticals logo

About Paratek Pharmaceuticals Stock (NASDAQ:PRTK)

Advanced Chart

Key Stats

Today's Range
$2.23
$2.23
50-Day Range
$2.17
$2.23
52-Week Range
$1.29
$3.65
Volume
N/A
Average Volume
724,253 shs
Market Capitalization
$127.82 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive PRTK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Paratek Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

PRTK Stock News Headlines

Presidential Bombshell: $150T Resource to Be Released as soon as this Summer?
Something extraordinary is happening in Washington. For the first time in over a century, a sitting President could release a national treasure that's been tied up in red tape, for generations. I'm talking about a $150 trillion American asset that's scattered across all 50 states. While the mainstream media focuses on political theater, this story is quietly developing behind closed doors.
Paratek Pharmaceuticals to acquire Optinose in $330M transaction
See More Headlines

PRTK Stock Analysis - Frequently Asked Questions

Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK) released its quarterly earnings data on Monday, November, 8th. The specialty pharmaceutical company reported ($0.37) EPS for the quarter, beating the consensus estimate of ($0.45) by $0.08. The specialty pharmaceutical company had revenue of $24.45 million for the quarter, compared to analysts' expectations of $22.98 million.

Based on aggregate information from My MarketBeat watchlists, some other companies that Paratek Pharmaceuticals investors own include Energy Transfer (ET), Sorrento Therapeutics (SRNE), Micron Technology (MU), Verastem (VSTM), Citius Pharmaceuticals (CTXR), SCYNEXIS (SCYX) and Aurinia Pharmaceuticals (AUPH).

Company Calendar

Last Earnings
11/08/2021
Today
7/12/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biotechnology
Sub-Industry
Pharmaceuticals
Current Symbol
NASDAQ:PRTK
Previous Symbol
NASDAQ:TSPT
CIK
1178711
Employees
268
Year Founded
1996

Profitability

EPS (Trailing Twelve Months)
($1.10)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$63.57 million
Net Margins
-35.44%
Pretax Margin
-35.35%
Return on Equity
N/A
Return on Assets
-40.05%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.52
Quick Ratio
0.46

Sales & Book Value

Annual Sales
$160.27 million
Price / Sales
0.80
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($3.08) per share
Price / Book
-0.72

Miscellaneous

Outstanding Shares
57,320,000
Free Float
52,736,000
Market Cap
$127.82 million
Optionable
Optionable
Beta
1.70

Social Links

7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

This page (NASDAQ:PRTK) was last updated on 7/13/2025 by MarketBeat.com Staff
From Our Partners